Bioness

Company Overview

Snapshot

Founded in March 1991 by Shmuel Shani, Bioness operates with 51–200 employees. The company was acquired by Accelmed in October 2024, marking a significant corporate milestone.

Business overview

Bioness develops medical technologies focused on neuromodulation systems, robotic systems, and software-based therapy programs. These solutions provide functional and therapeutic benefits for individuals with central nervous system disorders and orthopedic injuries. The company's products aim to enhance efficiencies, improve patient outcomes, and increase safety for healthcare providers, primarily serving the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In January 2025, Bioness Medical, Inc. re-established itself as an independent neuro rehabilitation-focused organization. This move signals a strategic pivot towards advancing patient outcomes through specialized neuro-rehabilitation, indicating a renewed focus and potential for innovation in this critical area of healthcare.

Company Intelligence Q&A

What is Bioness's primary focus?

Bioness specializes in developing medical technologies, including neuromodulation and robotic systems, along with software-based therapy programs, for individuals affected by central nervous system disorders and orthopedic injuries.

When was Bioness acquired by Accelmed?

Bioness was acquired by Accelmed in October 2024.

What was a key strategic development for Bioness in early 2025?

In January 2025, Bioness Medical, Inc. re-established itself as an independent neuro rehabilitation-focused organization, aiming to advance patient outcomes.

Who founded Bioness?

Bioness was founded by Shmuel Shani in March 1991.